Biosimilar medicines in inflammatory bowel disease
Tidsskr Nor Laegeforen. 2014 Apr 29;134(8):819-20.
doi: 10.4045/tidsskr.14.0192.
[Article in
English,
Norwegian]
No abstract available
MeSH terms
-
Anti-Inflammatory Agents, Non-Steroidal / economics
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Antibodies, Monoclonal / economics
-
Antibodies, Monoclonal / therapeutic use
-
Biosimilar Pharmaceuticals* / economics
-
Biosimilar Pharmaceuticals* / standards
-
Biosimilar Pharmaceuticals* / therapeutic use
-
Humans
-
Inflammatory Bowel Diseases / drug therapy*
-
Infliximab
-
Therapeutic Equivalency
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antibodies, Monoclonal
-
Biosimilar Pharmaceuticals
-
Infliximab